Relationship between pro-anti-inflammatory cytokines, T-cell activation and CA 125 in obese patients with heart failure

Medical Science Monitor

Volumn 17, Issue 3, 2011, Pages 13-

  Hamdy, Nadia M ^a  

^a Ain Shams University   (Egypt)

Author keywords

CA 125; Heart failure; Obesity; Pro anti inflammatory cytokines; T cell activation

Indexed keywords

CA 125 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PROTEIN BLOOD LEVEL; T LYMPHOCYTE ACTIVATION;

EID: 79952381318     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.881453     Document Type: Article

References (23)

1. Monteiro S, Franco F, Costa S et al: Prognostic value of CA125 in advanced heart failure patients. Int J Cardiol, 2010; 140(1): 115-18
2. Turgut O, Tandogana I, Yilmaza MB et al: CA125 levels among patients with advanced heart failure: An emerging independent predictor for survival. Int J Cardiol, 2010; 145(1): 71
3. Kosar F, Aksoy Y, Ozguntekin G et al: Relationship between cytokines and tumour markers in patients with chronic heart failure. Eur J Heart Fail, 2006; 8: 270-74
4. Opal SM, DePalo VA: Anti-inflammatory cytokines. Chest, 2000; 117: 1162-72
5. Abbate A, Vecile E, Fiotti N et al: Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction. Eur J Heart Fail, 2003; 5(1): 23-25
6. Perik PJ, de Vries EGE, JA et al: Serum HER2 levels are increased in patients with chronic heart failure. Eur J Heart Fail, 2007; 9: 173-77
7. Ramos AM, Pelland LC, Gus I, Portal VL: Inflammatory markers of cardiovascular disease in the elderly. Arq. Bras. Cardiol, 2009; 92(3): 233-40
8. Piotrowski G, Gawor R, Banach M et al: High sensitivity C-reactive protein, NT-proBNP and hemodynamic left ventricular function in acute coronary syndrome without ST segment elevation - a preliminary report. Med Sci Monit, 2010; 16(7): CR313-17
9. Pasic J, Levy WC, Sullivan MD: Cytokines in Depression and Heart Failure. Psychosomatic Medicine, 2003; 65: 181-93
10. Caforioa ALP, Goldmanb JH, Baigb MK et al: Elevated serum levels of soluble interleukin-2 receptor, neopterin and b-2-microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis. Eur J Heart Fail, 2001; 3(2): 155-63
11. Lavie CJ, Milani RV, Ventura HO, Romero-Corral A: Body Composition and Heart Failure Prevalence and Prognosis: Getting to the Fat of the Matter in the "Obesity Paradox. Mayo Clinic Proceedings, 2010; 85(7): 605-8
12. Kourisa NT, Zacharosb ID, Kontogiannia DD et al: The significance of CA 125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters. Eur J Heart Fail, 2005; 7: 199-203
13. Varol E, OzaydNn M, Dogan A, Kosar F: Tumour marker levels in patients with chronic heart failure. Eur J Heart Fail, 2005; 7(5): 840-43
14. Kenemans P, Yedema CA, Bon GG: CA 125 in gynecological pathology: a review. Eur J Obstet Gynecol Reprod Biol, 1993; 49: 115-24
15. Vander Burg ME, Lammes FB, Verwei JJ: CA 125 in ovarian cancer. Neth J Med, 1992; 40: 36-51
16. Bergmann JF, Bidart JM, George M et al: Elevation of CA 125 in patients with benign and malignant ascites. Cancer, 1987; 59: 213-17
17. Molina R, Filella X, Bruix J et al: Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem, 1991; 37: 1379-83
18. Turk HM, Pekdemir H, Buyukberber S et al: Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid. Tumor Biol, 2003; 24: 172-75
19. Duman C, Ercan E, Tengiz I et al: Elevated serum CA 125 levels in mitral stenotic patients with heart failure. Cardiology, 2003; 100(1): 7-10
20. Libby P, Ridker PM, Hansson GK: For the Leducq Transatlantic Network on Atherothrombosis, Inflammation in Atherosclerosis: From Pathophysiology to Practice. J Am Coll Cardiol, 2009; 54: 2129-38
21. Jermendy A, Korner A, Kovacs M et al: Association between toll-like receptor polymorphisms and serum levels of tumor necrosis factor-a and its soluble receptors in obese children. Med Sci Monit, 2010; 16(4): CR180-85
22. Zeimet AG, Offner FA, Marth C et al: Modulation of CA 125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells. Anticancer Res, 1997; 17: 3129-31
23. Kubonishi I, Bandobashi K, Murata N et al: High serum levels of CA125 and interleukin-6 in a patient with Ki-1 lymphoma. Br J Haematol, 1997; 98(2): 450-52